Obagi Medical - Best Pharma Stocks of 2007
Company: Obagi Medical
Starting stock price: $9.85
Ending stock price: $18.33
Percent Change: 86.09%
Details: Obagi Medical Products has developed prescription-strength skin health systems focused on preventing and/or improving skin conditions including photodamage, hyperpigmentation (chloasma, melasma, freckles), acne, vulgaris and rosacea. The company went public in October 2007.
More stories about Obagi Medical
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: